文献速递其他结缔组织病

胸部MRI联合CT评估系统性硬化症患者间质性肺病进展

Chest MRI with CT in the assessment of interstitial lung disease progression in patients with systemic sclerosis.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

这项前瞻性单中心观察性研究纳入系统性硬化症(SSc)患者,采用硬皮病肺研究(SLS)I评分系统视觉评估胸部MRI,并与CT、肺功能检查(PFT)结果进行相关性分析。以疾病进展为金标准,MRI与CT评分的AUC分别为0.86(0.72-0.98;P=0.04)和0.83(0.70-0.99;P=0.05)。作者认为SSc患者的MRI评分可能可作为评估ILD进展的替代方法。

要点

  • MRI评分与CT评分均与%FVC及DLCO存在相关性。
  • MRI评分预测ILD进展的AUC为0.86(0.72-0.98;P=0.04)。
  • MRI评分敏感度85%、特异度87.5%、PPV 88.34%、NPV 86.11%。

核心结论

  • 作者认为SSc患者的MRI评分可能可作为评估SSc相关ILD进展的替代方法。

研究设计与样本

  • 前瞻性单中心观察性研究,纳入诊断为SSc的患者。
  • 采用硬皮病肺研究(SLS)I评分系统对MRI图像进行视觉评估。
  • 以疾病进展为金标准,用Harrel's c-index计算CT和MRI评分的AUC,并通过ROC曲线最大Youden指数确定预测疾病进展的最佳阈值(P<0.05)。

主要发现

  • MRI评分与CT评分预测疾病进展的AUC分别为0.86(0.72-0.98;P=0.04)和0.83(0.70-0.99;P=0.05)。
  • MRI评分与%FVC相关(r=-0.54,P=0.0045),CT评分与%FVC相关(r=-0.44,P=0.137)。
  • MRI评分与DLCO相关(r=-0.39,P=0.007),CT评分与DLCO相关(r=-0.36,P=0.006)。
  • MRI评分的敏感度、特异度、PPV和NPV分别为85%、87.5%、88.34%和86.11%。
  • CT评分的敏感度、特异度、PPV和NPV分别为84.21%、82.35%、84.14%和82.4%。

关键数值与推荐

  • MRI评分预测ILD进展的AUC为0.86(0.72-0.98;P=0.04)。
  • CT评分预测ILD进展的AUC为0.83(0.70-0.99;P=0.05)。
  • MRI评分与%FVC的相关系数r=-0.54(P=0.0045),与DLCO的相关系数r=-0.39(P=0.007)。
  • CT评分与%FVC的相关系数r=-0.44(P=0.137),与DLCO的相关系数r=-0.36(P=0.006)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the performance of CT and MRI in the assessment of the progression of interstitial lung disease (ILD) associated with SSc and demonstrate the correlations of MRI with pulmonary function test (PFT) and CT scores. METHODS: This prospective single-centre observational study included patients with SSc diagnoses, and magnetic resonance (MR) images were assessed visually using the Scleroderma Lung Study (SLS) I system. Differences in the median scores were assessed with Student's t-test and the Wilcoxon rank-sum test. Pearson's and Spearman's rank correlation coefficients were calculated to correlate imaging scores and PFT results. Using disease progression as the gold standard, we calculated the area under the curve (AUC) of the CT and MRI scores with Harrel's c-index. The best thresholds for the prediction of disease progression were determined by receiver operating characteristic curve analysis with maximum Youden's Index (P < 0.05). The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of the scores were calculated. RESULTS: The AUCs for MRI and CT scores were 0.86 (0.72-0.98; P = 0.04) and 0.83 (0.70-0.99; P = 0.05), respectively. CT and MRI scores correlated with Forced vital capacity (%FVC) (MRI: r = -0.54, P = 0.0045; CT: r = -0.44; P = 0.137) and diffusing capacity of the lung for carbon monoxide (MRI: r = -0.39, P = 0.007; CT r = -0.36, P = 0.006). The sensitivity, specificity, PPV and NPV were 85%, 87.5%, 88.34% and 86.11% (MRI score) and 84.21%, 82.35%, 84.14% and 82.4% (CT score), respectively. CONCLUSIONS: MRI scores from patients with SSc may be an alternative modality for the assessment of ILD progression in patients with SSc.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Hochhegger B, Lonzetti L, Rubin A, et al. Chest MRI with CT in the assessment of interstitial lung disease progression in patients with systemic sclerosis. Rheumatology (Oxford). 2022. PMID: 35258556. doi:10.1093/rheumatology/keac148

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。